Degussa strengthens position with purchase of Genset Oligos
Germany-based Degussa Group is buying Genset Oligos, the oligonucleotide division of French company Genset for US$ 21.5 million (€24.53m), and will merge it with Proligo, its subsidiary based in Boulder, Colorado.